Wrinkles

... BOTOX® Makers Get UK Approval For VISTABEL For Cosmetic Use For The Treatment Of Glabellar Lines (Vertical ‘Frown' Lines) @import "css/default.css"; @import "css/defaultnews.css"; if (screen.width > 1000) document.write(''); 19th March 2006 home xml feeds newsletter advertise accessibility contact Archive Search Medical Abbreviations BOTOX® Makers Get UK Approval For VISTABEL For Cosmetic Use For The Treatment Of Glabellar Lines (Vertical ‘Frown' Lines) Main Category: Cosmetic Medicine/Plastic Surgery News Article Date: 19 Mar 2006 - 0:00am (UK)Allergan Ltd.

today announced that VISTABEL® (botulinum toxin type A) has been granted a licence in the UK from the Medicines and Healthcare products Regulatory Agency (MHRA) for the temporary improvement in the appearance of moderate to severe glabellar lines (vertical ‘frown' lines between the brows) in adult women and men aged 65 and younger, when the severity of these lines has a psychological impact for the patient.

With dosing specific to treat glabellar lines, BOTOX® for cosmetic use will be marketed in the UK under the brand name VISTABEL® and is the only brand of botulinum toxin type A licensed for cosmetic use in the UK.

“VISTABEL® has proven to be an effective treatment option for minimising wrinkles between the brows, achieving a naturally refreshed and relaxed upper face rejuvenation that so many people are seeking today,” said Dr Nick Lowe, Consultant Dermatologist, Cranley Clinic, London.

“The licensing of VISTABEL®...

Read more...